Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111116501B details a novel catalytic method for synthesizing Lesinurad intermediates, eliminating chlorinated impurities and ensuring scalable API production.
Patent CN116554014B reveals high-purity fenofibrate preparation with improved impurity control and scalable commercial manufacturing capabilities for global supply chains.
Patent CN106892859B reveals a novel benzo[c,d]indole-polyamine conjugate with superior lysosome targeting and anti-metastasis activity for pharmaceutical manufacturing.
Novel 6-step synthesis from epoxy-pregnane. High yield, industrial scale. Cost-effective veterinary hormone intermediate manufacturing.
Novel 4-step synthesis route for Abiraterone acetate improves yield to 51.4% with mild conditions, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN116082111B reveals chromium catalysis for 1,1,2-triarylethane. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel eight-step synthesis from L-asparagine avoids chiral resolution, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103626822B details a high-yield, mercury-free synthesis of 25-hydroxycholesterol, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106478623B reveals high-yield triazole isoquinoline synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel patent CN104725322B details efficient 2-aminopyrimidine synthesis. Offers high yield and cost advantages for supply chain stability and commercial scalability in drug manufacturing.
Patent CN102070497B reveals a novel four-step synthesis for florfenicol. This method offers mild conditions and high yields, ensuring cost reduction and supply chain reliability for global buyers.
Patent CN101153030B details a novel photochemical route from abundant triterpenoids to chiral decalin intermediates, offering significant cost reduction and supply chain stability for fragrance and pharmaceutical manufacturing.
Patent CN119707868A details a novel synthesis for Viloxazine Impurity C enabling high-purity quality control and streamlined supply chain management for global pharmaceutical manufacturers.
Patent CN107176948B details a safer pimobendan route eliminating toxic reagents. This offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Novel binaphthyl-based phase transfer catalyst offering high enantioselectivity up to 98% ee. Ideal for pharmaceutical intermediates manufacturing with scalable processes.
Patent CN110483460A reveals a room-temperature PIFA oxidation method for 3-selenocoumarin. Discover cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN115557873A details a novel asymmetric synthesis for Brivaracetam methyl ester impurity, offering high purity and cost-effective production for quality control standards.
Patent CN111925312A reveals a novel one-pot synthesis for indolyl-substituted indole-3-ketones using PPh3. This method offers significant cost reduction in API manufacturing and high purity.
Patent CN109518211B details a green electrochemical route to aromatic acyl compounds, eliminating metal catalysts for cost-effective pharmaceutical intermediate manufacturing.
Patent CN113667006B reveals a novel liquid-phase route for Semaglutide intermediates offering high purity and scalable manufacturing solutions for global pharmaceutical supply chains.